title: Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation.
authors: Magdalena C
authors: MC
authors: Denk
authors: Christiane
authors: C
authors: Rewerts
authors: Florian
authors: F
authors: Holsboer
authors: Angelika
authors: A
authors: Erhardt-Lehmann
authors: Christoph W
authors: CW
authors: Turck
mesh_terms: D000293:Adolescent; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007649:Ketamine / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010766:Phosphorylation; D051381:Rats; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D020123:Sirolimus / Q000378:metabolism*; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D020123:Sirolimus